Trials / Completed
CompletedNCT02681484
Effects of Speech-therapy in Hypertensive Patients
Speech Guided Breathing: a Modality to Influence Cardiovascular Regulation and Health Perception in Hypertensive Patients?
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 31 (actual)
- Sponsor
- Klinik Arlesheim · Academic / Other
- Sex
- All
- Age
- 20 Years – 60 Years
- Healthy volunteers
- Not accepted
Summary
Anthroposophic speech therapy (ATS) has been shown to positively influence heart rate variability (HRV) and heart rate - respiration coordination in healthy volunteers. This study was performed to learn more about such improvements and possible alteration in baroreflex sensitivity (BRS) in hypertensive patients, which characteristically differ in those regulatory parameters from normotensive patients
Detailed description
In this prospective, primarily pre-post study, patients received three ATS treatments in alternation with three control sessions (casual talking with the therapist). In order to perform HRV-analysis and BRS determination blood pressure and ECG were continuously recorded during the sessions. Changes in subjective well-being and perceived health were assessed by questionnaire before and after the various sessions (mood questionaire). Thirty-one patients participated in this study, the majority diagnosed with arterial hypertension (22 out of 31).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Anthroposophic speech therapy | Anthroposophic speech therapy uses sound-combinations like "KLSFM" or "OM" and hexameter verse in German, spoken by the therapist and imitated by the patients, to expand and decelerate respiration. The intervention is conducted by the same qualified therapist for one patient in different days but during the same daytime for 30 minutes in upright position and walking. |
Timeline
- Start date
- 2002-09-01
- Primary completion
- 2008-04-01
- Completion
- 2008-04-01
- First posted
- 2016-02-12
- Last updated
- 2016-02-12
Source: ClinicalTrials.gov record NCT02681484. Inclusion in this directory is not an endorsement.